

Author: Mark J. Greener Julian F. Guest
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.19, Iss.3, 2005-01, pp. : 253-264
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Which therapies could reduce the burden of OA?
Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. :


Which therapies could reduce the burden of OA?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 449, 2004-01 ,pp. :


Do Drugs Reduce Utilisation of Other Healthcare Resources?
PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. :


Morphological Brain Changes in Depression: Can Antidepressants Reverse Them?
By Miguel-Hidalgo J.J. Rajkowska G.
CNS Drugs, Vol. 16, Iss. 6, 2002-01 ,pp. :